tiprankstipranks
RPSG Ventures Limited (IN:RPSGVENT)
:RPSGVENT
India Market
Want to see IN:RPSGVENT full AI Analyst Report?

RPSG Ventures Limited (RPSGVENT) AI Stock Analysis

0 Followers

Top Page

IN:RPSGVENT

RPSG Ventures Limited

(RPSGVENT)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 5.2)
Rating:50Neutral
Price Target:
₹830.00
▲(9.40% Upside)
Action:Reiterated
Date:05/28/26
The score is held back primarily by financial performance—persistent net losses, higher leverage, and weaker FY2026 free cash flow—despite steady revenue growth and reasonable operating margins. Technicals are moderately supportive (positive MACD and price above key longer-term averages), but valuation is constrained by loss-making earnings and no dividend yield data.
Positive Factors
Steady revenue growth
Sustained top-line expansion indicates the group’s portfolio and incubated businesses are gaining traction. Durable revenue growth supports reinvestment, improves bargaining with partners, and provides a firmer base for future monetizations or exits, lowering execution risk over months.
Negative Factors
Persistent net losses
Ongoing net losses erode retained equity and limit the company’s ability to self-fund growth or pay dividends. Even with operating earnings, below-the-line items (interest, D&A, other charges) keep the firm loss-making, forcing reliance on external capital or asset sales to sustain investment activity.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady revenue growth
Sustained top-line expansion indicates the group’s portfolio and incubated businesses are gaining traction. Durable revenue growth supports reinvestment, improves bargaining with partners, and provides a firmer base for future monetizations or exits, lowering execution risk over months.
Read all positive factors

RPSG Ventures Limited (RPSGVENT) vs. iShares MSCI India ETF (INDA)

RPSG Ventures Limited Business Overview & Revenue Model

Company Description
RPSG Ventures Limited is an Indian enterprise with a diversified portfolio, engaging in the ownership, operation, investment, and promotion of businesses spanning information technology, business process outsourcing, real estate, entertainment, fa...
How the Company Makes Money
RPSG Ventures Limited primarily makes money through returns generated from its investments and holdings. Key revenue and earnings drivers typically include (i) dividend income received from portfolio/associate/subsidiary companies, (ii) interest i...

RPSG Ventures Limited Financial Statement Overview

Summary
Mixed fundamentals: steady revenue growth and reasonable operating margins are offset by persistent net losses, materially rising leverage (debt-to-equity ~3.29x in FY2026), and a FY2026 shift to negative free cash flow.
Income Statement
52
Neutral
Balance Sheet
34
Negative
Cash Flow
43
Neutral
BreakdownMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue113.23B96.08B79.51B71.66B66.70B
Gross Profit45.82B42.74B32.27B28.33B26.70B
EBITDA16.35B13.73B13.06B9.44B9.25B
Net Income-1.38B-490.40M-424.60M-1.53B1.31B
Balance Sheet
Total Assets190.49B162.22B139.75B131.59B128.01B
Cash, Cash Equivalents and Short-Term Investments9.67B10.12B7.19B5.58B4.03B
Total Debt82.43B61.52B42.11B34.14B28.07B
Total Liabilities146.68B116.34B95.15B91.52B87.26B
Stockholders Equity25.06B26.63B26.67B24.05B25.26B
Cash Flow
Free Cash Flow-1.06B7.68B2.17B-733.30M-1.66B
Operating Cash Flow8.55B10.97B10.38B7.26B6.60B
Investing Cash Flow-21.34B-15.90B-11.36B-7.17B-14.54B
Financing Cash Flow12.33B7.54B2.91B2.52B8.56B

RPSG Ventures Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price758.65
Price Trends
50DMA
905.75
Positive
100DMA
848.05
Positive
200DMA
813.00
Positive
Market Momentum
MACD
3.33
Negative
RSI
56.25
Neutral
STOCH
41.82
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:RPSGVENT, the sentiment is Positive. The current price of 758.65 is below the 20-day moving average (MA) of 878.02, below the 50-day MA of 905.75, and below the 200-day MA of 813.00, indicating a bullish trend. The MACD of 3.33 indicates Negative momentum. The RSI at 56.25 is Neutral, neither overbought nor oversold. The STOCH value of 41.82 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:RPSGVENT.

RPSG Ventures Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
₹50.00B25.490.58%15.31%-5.35%
73
Outperform
₹54.94B13.371.62%7.55%7.12%
63
Neutral
₹57.82B27.071.26%12.34%14.85%
62
Neutral
₹30.26B13.913.06%18.27%49.59%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
50
Neutral
₹29.49B-21.7917.85%-181.36%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:RPSGVENT
RPSG Ventures Limited
907.65
-24.45
-2.62%
IN:DATAMATICS
Datamatics Global Services Limited
838.90
67.35
8.73%
IN:HAPPSTMNDS
Happiest Minds Technologies Ltd.
382.40
-231.13
-37.67%
IN:MASTEK
Mastek Limited
1,744.20
-884.70
-33.65%
IN:RSYSTEMS
R Systems International Limited
249.90
-191.40
-43.37%

RPSG Ventures Limited Corporate Events

RPSG Ventures Restructures Healthcare Portfolio with Clarionix Acquisition and Woodlands Merger Plan
Jun 25, 2026
RPSG Ventures Limited has acquired 100% of Clarionix Healthcare Private Limited, making it a wholly owned subsidiary, as part of a broader restructuring of its healthcare interests. The move strengthens the group’s healthcare platform and pr...
RPSG Ventures Restructures Healthcare Portfolio with Clarionix Acquisition and Woodlands Merger
Jun 25, 2026
RPSG Ventures Limited has acquired 100% of Clarionix Healthcare Private Limited, making it a wholly owned subsidiary as part of a broader strategic push into healthcare. The move allows the company to consolidate healthcare assets under its umbrel...
RPSG Ventures Restructures Healthcare Portfolio With Clarionix Acquisition and Woodlands Merger
Jun 25, 2026
RPSG Ventures Limited has acquired 100% of Clarionix Healthcare Private Limited, making it a wholly owned subsidiary and positioning the new entity as a dedicated vehicle within the group’s healthcare portfolio. The move reflects the company...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 28, 2026